Cancer Treatment
Studies from Canada, Japan and France add new findings to cancer treatment body of knowledge
Published in Vaccine Weekly, August 23rd, 2006
Study 1: Recent research from Canada has reported on the technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas.
"Malignant glioblastomas and melanomas continue to have a dismal prognosis despite advances in conventional therapy. This has led to investigations of novel treatment strategies including immunogene therapy. We report a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for gliomas and melanomas and discuss technical hurdles encountered," wrote I.F. Parney and colleagues,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-08-23)
More Articles from Vaccine Weekly
- Autoimmune Disease
Antibodies to polysaccharides protect against severe infection in C2 deficiency - Mononucleosis Risk Factors
Infectious mononucleosis vaccine may need only to reduce viral load - Proteomics
Mouse neural stem cells that stably express human nerve growth factor are characterized - Tuberculosis Vaccine
Complications associated with BCG vaccine in Ireland are outlined - Avian Influenza
Bird flu virus NS1 gene was progressively truncated after circulation in poultry - Avian Influenza
HepaLife continues bird flu vaccine development, discusses new report on influenza - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
